The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Dr. Charles M. Rudin discussed recent treatment advancements for patients with small cell lung cancer. During the CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York ...

COLUMBUS, Ohio — There's word of some advancements in treating one of the most aggressive and deadly types of lung cancer. Small cell lung cancer accounts for 15% of lung cancer cases and it has a ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

American Lung Association's 'State of Lung Cancer' report reveals new national lung cancer data, calls on states to ensure access to care CHICAGO, Nov. 5, 2025 /PRNewswire/ -- Today, the American Lung ...

The Lung Cancer Research Foundation® (LCRF) recently awarded five new research grants in the following areas: three LCRF ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

Lung cancer is hard to catch early and even harder to survive once it is found. A new clinical trial will test whether a ...

CHARLESTON, S.C. (WCSC) - Living with lung cancer often means spending more time in waiting rooms than in the moments that matter, but a new South Carolina research project hopes to change that by ...

We currently know that COPD, and specifically emphysema, don’t just happen alongside lung cancer; they increase a person’s ...